XML 58 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common stock
Additional paid-In Capital
Stock option receivable
Accumulated deficit
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2016   18,438,742        
Beginning balance at Dec. 31, 2016 $ 54,957 $ 1 $ 211,125 $ (75) $ (151,576) $ (4,518)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock under Employee Stock Purchase Plan (in shares)   16,263        
Issuance of common stock under Employee Stock Purchase Plan 180   180      
Issuance of common stock upon exercise of options (in shares)   269,842        
Issuance of common stock upon exercise of options 705   630 75    
Stock‑based compensation expense 4,080   4,080      
Issuance of common stock, license agreement (in shares)   529,616        
Issuance of common stock, license agreement 10,000   10,000      
Issuance of common stock through private placement, net (in shares)   3,088,791        
Issuance of common stock through private placement, net of issuance costs of $37 47,115 $ 2 47,113      
Currency translation adjustment 78         78
Unrealized gains (losses) on securities 20         20
Net loss (65,321)       (65,321)  
Ending balance (in shares) at Dec. 31, 2017   22,343,254        
Ending balance at Dec. 31, 2017 51,814 $ 3 273,128 0 (216,897) (4,420)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock under Employee Stock Purchase Plan (in shares)   24,738        
Issuance of common stock under Employee Stock Purchase Plan 196   196      
Issuance of common stock upon exercise of options (in shares)   103,784        
Issuance of common stock upon exercise of options 501   501      
Stock‑based compensation expense 5,714   5,714      
Currency translation adjustment (153)         (153)
Unrealized gains (losses) on securities 16         16
Net loss $ (65,336)       (65,336)  
Ending balance (in shares) at Dec. 31, 2018 22,471,776 22,471,776        
Ending balance at Dec. 31, 2018 $ (5,418) $ 3 279,539 0 (280,403) (4,557)
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock under Employee Stock Purchase Plan (in shares)   17,205        
Issuance of common stock under Employee Stock Purchase Plan 28   28      
Issuance of common stock upon exercise of options (in shares)   125,600        
Issuance of common stock upon exercise of options 150   150      
Stock‑based compensation expense 5,161   5,161      
Issuance of common stock through private placement, net (in shares)   3,178,174        
Issuance of common stock through private placement, net of issuance costs of $37 5,715   5,715      
Issuance of common stock, pre-funded warrants and warrants through private placement, net of issuance costs (in shares)   37,634,883        
Issuance of common stock, pre-funded warrants and warrants through private placement, net of issuance costs 26,129 $ 4 26,125      
Currency translation adjustment 34          
Unrealized gains (losses) on securities 0          
Net loss (55,350)          
Issuance of common stock, net of issuance costs (in shares)   22,188,706        
Issuance of common stock, net of issuance costs 30,942 $ 2 30,940      
Issuance of common stock through at-the-market offering, net (in shares)   615,453        
Issuance of common stock through at-the-market offering, net 1,006   1,006      
Issuance of restricted stock units (in shares)   93,750        
Issuance of restricted stock units $ 0          
Ending balance (in shares) at Dec. 31, 2019 86,325,547 86,325,547        
Ending balance at Dec. 31, 2019 $ 8,397 $ 9 $ 348,664 $ 0 $ (335,753) $ (4,523)